Drug Profile
EHC 18
Alternative Names: EHC18Latest Information Update: 01 Sep 2009
Price :
$50
*
At a glance
- Originator Enzo Biochem
- Class Antineoplastics; Antivirals
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hepatitis C
- Discontinued Liver cancer
Most Recent Events
- 07 Dec 2006 Clinical development is still ongoing